Conduction system pacing was found to be inferior to biventricular pacing for key outcomes in HFrEF with left bundle-branch ...
Conduction-system pacing (CSP) was put to the test in two randomized trials of patients requiring cardiac resynchronization therapy (CRT) for left bundle branch block (LBBB)—the HeartSync-LBBP and ...
Late-breaking data from Abbott (ABT)'s groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker Enrollment has ...
Abbott (ABT)'s investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system is specifically designed to deliver pacing to the left bundle branch area, activating the heart's natural ...
The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy. The ...
The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy. The ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...
(RTTNews) - Abbott (ABT) announced the successful completion of the world's first in-human leadless left bundle branch area pacing procedures using the company's investigational AVEIR Conduction ...
Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results